Kelly-Spratt KS - Search Results

1

Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.

Kelly-Spratt KS, Philipp-Staheli J, Gurley KE, Hoon-Kim K, Knoblaugh S, Kemp CJ. Kelly-Spratt KS, et al. Oncogene. 2009 Oct 15;28(41):3652-62. doi: 10.1038/onc.2009.226. Epub 2009 Aug 3. Oncogene. 2009. PMID: 19648963 Free PMC article.

2

p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.

Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ. Ruddell A, et al. Oncogene. 2008 May 15;27(22):3145-55. doi: 10.1038/sj.onc.1210973. Epub 2007 Dec 3. Oncogene. 2008. PMID: 18059331

3

ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.

Busch SE, Moser RD, Gurley KE, Kelly-Spratt KS, Liggitt HD, Kemp CJ. Busch SE, et al. Among authors: kelly spratt ks. Oncogene. 2014 May 15;33(20):2665-73. doi: 10.1038/onc.2013.208. Epub 2013 Jun 10. Oncogene. 2014. PMID: 23752194 Free PMC article.

4

p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.

Kelly-Spratt KS, Gurley KE, Yasui Y, Kemp CJ. Kelly-Spratt KS, et al. PLoS Biol. 2004 Aug;2(8):E242. doi: 10.1371/journal.pbio.0020242. Epub 2004 Aug 17. PLoS Biol. 2004. PMID: 15314658 Free PMC article.

5

A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.

Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. Besson A, et al. Genes Dev. 2006 Jan 1;20(1):47-64. doi: 10.1101/gad.1384406. Genes Dev. 2006. PMID: 16391232 Free PMC article.

6

Tumor suppression by p53 in the absence of Atm.

Bailey SL, Gurley KE, Hoon-Kim K, Kelly-Spratt KS, Kemp CJ. Bailey SL, et al. Mol Cancer Res. 2008 Jul;6(7):1185-92. doi: 10.1158/1541-7786.MCR-07-2009. Epub 2008 Jun 26. Mol Cancer Res. 2008. PMID: 18583527 Free PMC article.

7

Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.

Schoenherr RM, Kelly-Spratt KS, Lin C, Whiteaker JR, Liu T, Holzman T, Coleman I, Feng LC, Lorentzen TD, Krasnoselsky AL, Wang P, Liu Y, Gurley KE, Amon LM, Schepmoes AA, Moore RJ, Camp DG 2nd, Chodosh LA, Smith RD, Nelson PS, McIntosh MW, Kemp CJ, Paulovich AG. Schoenherr RM, et al. Among authors: kelly spratt ks. Proteomics Clin Appl. 2011 Apr;5(3-4):179-88. doi: 10.1002/prca.201000037. Epub 2011 Feb 15. Proteomics Clin Appl. 2011. PMID: 21448875 Free PMC article.

8

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM. Taguchi A, et al. Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007. Cancer Cell. 2011. PMID: 21907921 Free PMC article.

9

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

Whiteaker JR, Zhang H, Zhao L, Wang P, Kelly-Spratt KS, Ivey RG, Piening BD, Feng LC, Kasarda E, Gurley KE, Eng JK, Chodosh LA, Kemp CJ, McIntosh MW, Paulovich AG. Whiteaker JR, et al. J Proteome Res. 2007 Oct;6(10):3962-75. doi: 10.1021/pr070202v. Epub 2007 Aug 21. J Proteome Res. 2007. PMID: 17711321

10

A mouse model repository for cancer biomarker discovery.

Kelly-Spratt KS, Kasarda AE, Igra M, Kemp CJ. Kelly-Spratt KS, et al. J Proteome Res. 2008 Aug;7(8):3613-8. doi: 10.1021/pr800210b. Epub 2008 Jul 15. J Proteome Res. 2008. PMID: 18624399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters